2-(p-Nitrophenyl)-2'-deoxyadenosine, a new type of mutagenic nucleoside. 1990

A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

A crude preparation of 2-phenyladenosine was found to be mutagenic in the Ames Salmonella assay. In the purification of this preparation, it was revealed that 2-phenyladenosine itself was nonmutagenic but that 2-(m- and p-nitrophenyl)-adenosines (5m,p) contaminating the sample were the mutagenic principles. A structure-activity relationship study was carried out, and it was found that 5p, 2-(p-nitrophenyl)-adenine (7p), and 2-(p-nitrophenyl)-2'-deoxyadenosine (15p) were strongly mutagenic toward S. typhimurium TA98 and TA100 without metabolic activation, the potency being in the order 15p greater than 7p greater than 5p. The potency of 15p in TA98 was one order of magnitude greater than that of 4-nitroquinoline N-oxide. 15p also showed mutagenicity in the mouse cell line FM3A in culture.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003839 Deoxyadenosines Adenosine molecules which can be substituted in any position, but are lacking one hydroxyl group in the ribose part of the molecule. Adenine Deoxyribonucleosides,Adenylyldeoxyribonucleosides,Deoxyadenosine Derivatives,Deoxyribonucleosides, Adenine,Derivatives, Deoxyadenosine
D000241 Adenosine A nucleoside that is composed of ADENINE and D-RIBOSE. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter. Adenocard,Adenoscan
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
January 1998, Acta biochimica Polonica,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
November 1964, Nature,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
January 2004, Nucleosides, nucleotides & nucleic acids,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
November 1967, Biochemical and biophysical research communications,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
June 2016, The journal of physical chemistry. B,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
May 2011, Nucleosides, nucleotides & nucleic acids,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
December 1983, Carbohydrate research,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
April 1948, Pharmazeutische Zentralhalle fur Deutschland,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
June 2004, Acta crystallographica. Section C, Crystal structure communications,
A Matsuda, and Y Ohara, and T Kakutani, and K Negishi, and Y Wataya, and H Hayatsu, and T Ueda
January 1987, Cancer chemotherapy and pharmacology,
Copied contents to your clipboard!